Efficacy of Single inhaler Maintenance And Reliever Therapy (SMART) with Spiromax budesonide/formoterol versus fixed dose treatment with Diskus fluticasone/salmeterol in COPD.

Trial Profile

Efficacy of Single inhaler Maintenance And Reliever Therapy (SMART) with Spiromax budesonide/formoterol versus fixed dose treatment with Diskus fluticasone/salmeterol in COPD.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2015

At a glance

  • Drugs Budesonide/formoterol (Primary) ; Salmeterol/fluticasone propionate
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top